Genetic engineering concept. Medical science. Scientific Laboratory.

Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea™ RNAP, Progresses Towards GMP Linea™ IVT Production Start

March 18, 2024

Read More email

Applied DNA Announces Joint Development Agreement to Integrate Linea™ IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow

December 14, 2023

Read More email

Applied DNA Extends Application of Linea™ IVT Platform to saRNA (self-amplifying mRNA)

November 16, 2023

Read More email

APDN Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals

September 14, 2023

Read More email

LineaRx to Participate in Upcoming mRNA Industry Conferences

July 18, 2023

Read More email

APDN Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT™ Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach

July 13, 2023

Read More email

APDN to Establish N. America’s 1st Enzymatic Large-Scale cGMP DNA Manufacturing Capacity in New York

October 24, 2022

Read More email

APDN Announces Receipt of Largest Single Purchase Order for LinearDNA™ To-Date

October 10, 2022

Read More email

LineaRx Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets

September 30, 2022

Read More email

APDN and the Cornell University College of Veterinary Medicine Announce Research Collaboration to Accelerate Application of LinearDNA™ Platform for Veterinary Health Applications

September 8, 2022

Read More email

LinearDNA™ Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles (LNP)

August 10, 2022

Read More email

LineaRx and EvviVax Publish Additional Positive Animal Proof-of-Concept Data Supporting LinearDNA™ Platform as a Unique Approach to Veterinary DNA Vaccine Development

July 25, 2022

Read More email

LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production at the 2nd Annual mRNA-Based Therapeutics Summit

July 22, 2022

Read More email

Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines

March 2, 2021

Read More email

APDN Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates

June 9, 2020

Read More email

APDN Provides Update on Linear-DNA COVID-19 Vaccine Candidates Development Program

June 8, 2020

Read More email

APDN and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals

May 4, 2020

Read More email

APDN High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital

April 21, 2020

Read More email

APDN Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing

April 15, 2020

Read More email

APDN Ships LinearDNA™ to Another Development Customer

March 26, 2020

Read More email

APDN Secures Top-20 Pharmaceutical Manufacturer as Drug Development Customer

March 20, 2020

Read More email

APDN Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection

March 19, 2020

Read More email

Stony Brook firm working on coronavirus vaccine

March 3, 2020

Read More email

APDN Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed

March 2, 2020

Read More email

LineaRx and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV

February 7, 2020

Read More email

LineaRx, Inc. Signs Licensing Agreement with LifeSensors

January 13, 2020

Read More email

LineaRx Signs Agreement with TYME Technologies for Functional ICTC Assay Services in Pancreatic Cancer Trial

November 26, 2019

Read More email

APDN Reports 14 Development Customers for its Linear DNA Manufacturing Platform

November 25, 2019

Read More email

LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction

September 19, 2019

Read More email

LineaRx Acquires Assets and Intellectual Property of Vitatex

August 8, 2019

Read More email

LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates

March 1, 2019

Read More email

LineaRx Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines

September 20, 2018

Read More email